Sesamol Alleviated Lipotoxicity-Induced Dysfunction in MIN6 Cells via Facilitating Cellular Senescence Caused by

Yan Xie1, Yongyan Tang1, Jinxin Yang1

  • 1Department of Nutrition and Food Hygiene, Xiangya School of Public Health, Central South University, Changsha, China.

Insights

Obesity causes type 2 diabetes mellitus (T2DM) via lipotoxicity. Sesamol, a sesame extract, combats this by reducing ER stress and TXNIP, protecting pancreatic beta cells and offering a potential T2DM treatment.

Area of Science:

  • Endocrinology and Metabolism
  • Cellular Biology
  • Nutraceutical Research

Background:

  • Obesity is a major risk factor for type 2 diabetes mellitus (T2DM).
  • Lipotoxicity-induced pancreatic beta-cell dysfunction is implicated, but mechanisms are unclear.
  • Understanding these mechanisms is crucial for developing effective T2DM therapies.

Purpose of the Study:

  • To elucidate the role of endoplasmic reticulum (ER) stress and TXNIP in lipotoxicity-driven beta-cell dysfunction.
  • To investigate the potential of sesamol, a natural compound, in mitigating this dysfunction.
  • To explore sesamol as a therapeutic agent for T2DM in obese individuals.

Main Methods:

  • Induction of lipotoxicity in MIN6 cells using a high-fat environment.
  • Assessment of ER stress markers and TXNIP protein levels.
  • Evaluation of sesamol's effects on beta-cell function and senescence markers.

Main Results:

  • Lipotoxicity activated ER stress and increased TXNIP protein levels in MIN6 cells.
  • This led to senescence-associated dysfunction in beta cells.
  • Sesamol treatment inhibited ER stress and TXNIP, alleviating lipotoxicity-induced beta-cell dysfunction.

Conclusions:

  • ER stress and TXNIP upregulation are key mediators of lipotoxicity-induced beta-cell senescence in T2DM.
  • Sesamol demonstrates therapeutic potential for T2DM by targeting ER stress and TXNIP.
  • Findings support sesamol as a novel treatment for T2DM in obese elderly populations.